Based in Israel, Teva is one of the world's largest generic drug manufacturers, with a portfolio of 3,500 products in nearly every therapeutic area. In addition to generics, Teva also focuses on specialty and biopharmaceutical products, primarily in the U.S. and Europe. The company's branded portfolio includes therapies for central nervous system conditions, oncology, and respiratory conditions. Teva is committed to providing access to quality medicine and has made significant investments in research and operations to support its growing portfolio.